文献速递中医内科中药与中成药合理使用

补肾活血汤通过抑制Rac1/PAK1/p38MAPK通路改善糖尿病肾病小鼠

Bu-Shen-Huo-Xue Decoction Ameliorates Diabetic Nephropathy by Inhibiting Rac1/PAK1/p38MAPK Signaling Pathway in High-Fat Diet/Streptozotocin-Induced Diabetic Mice.
PubMed 文献 · Front Pharmacol · 2020-12-03

本研究建立高脂饮食/链脲佐菌素诱导的糖尿病小鼠模型,给予补肾活血汤治疗,并采用UPLC-Q-TOF-MS分析其化学成分。结果显示补肾活血汤可改善肾功能指标、肾脏病理及足细胞上皮-间质转化,机制与抑制Rac1/PAK1/p38MAPK信号通路有关,并鉴定了67种化合物(含20种潜在活性成分)。

要点

  • 补肾活血汤可改善糖尿病小鼠肾功能指标及肾脏病理损伤。
  • 补肾活血汤可逆转足细胞上皮-间质转化标志物表达异常。
  • 其机制与抑制Rac1/PAK1/p38MAPK信号通路相关。

核心结论

  • 补肾活血汤通过抑制Rac1/PAK1/p38MAPK信号通路改善高脂饮食/链脲佐菌素诱导的糖尿病小鼠肾功能及足细胞上皮-间质转化。

研究设计与样本

  • 研究采用高脂饮食/链脲佐菌素诱导的糖尿病小鼠模型,并给予补肾活血汤治疗。
  • 采用UPLC-Q-TOF-MS分析补肾活血汤的化学成分和活性化合物。
  • 检测足细胞上皮-间质转化标志物及Rac1/PAK1/p38MAPK信号通路相关指标。

主要发现

  • 补肾活血汤有效缓解糖尿病症状,改善血清肌酐、血尿素氮、血清尿酸和尿白蛋白排泄率等肾功能指标。
  • 补肾活血汤改善糖尿病肾病小鼠的肾脏组织病理学和超微结构病理。
  • 在糖尿病小鼠肾脏中,足细胞标志物nephrin和podocin下调,间充质标志物α-SMA和FSP-1上调,补肾活血汤治疗可逆转这些变化。
  • 糖尿病小鼠中GTP-Rac1明显过表达,补肾活血汤可显著降低其水平;p-PAK1和p-p38MAPK水平在补肾活血汤治疗后也降低。
  • 从补肾活血汤中鉴定出67种化合物,包括20种潜在活性化合物,并建立了质量控制标准。

关键数值与推荐

  • 补肾活血汤中鉴定出67种化合物,其中20种为潜在活性化合物。

临床怎么用

  • 补肾活血汤在糖尿病肾病小鼠模型中显示改善肾功能和肾脏病理的作用,其机制涉及抑制Rac1/PAK1/p38MAPK通路。
  • 该研究为补肾活血汤治疗糖尿病肾病提供了实验依据,并建立了质量控制标准和潜在活性化合物基础。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Diabetic nephropathy (DN), a leading cause of end-stage renal disease, is associated with high morbidity and mortality rates worldwide and the development of new drugs to treat DN is urgently required. Bu-Shen-Huo-Xue (BSHX) decoction is a traditional Chinese herbal formula, made according to traditional Chinese medicine (TCM) theory, and has been used clinically to treat DN. In the present study, we established a high-fat diet/streptozotocin-induced diabetic mouse model and treated the mice with BSHX decoction to verify its therapeutic effects in vivo. Ultraperformance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry (UPLC-Q-TOF-MS) was applied to analyze the chemical composition and active compounds of BSHX decoction. Markers of podocyte epithelial-mesenchymal transition and the Rac1/PAK1/p38MAPK signaling pathway were evaluated to investigate the mechanism underlying function of BSHX decoction. BSHX decoction effectively alleviated diabetic symptoms, according to analysis of the renal function indicators, serum creatinine, blood urea nitrogen, serum uric acid, and urinary albumin excretion rate, as well as renal histopathology and ultrastructural pathology of DN mice. We identified 67 compounds, including 20 likely active compounds, in BSHX decoction. The podocyte markers, nephrin and podocin, were down-regulated, while the mesenchymal markers, α-SMA and FSP-1, were up-regulated in DN mouse kidney; however, the changes in these markers were reversed on treatment with BSHX decoction. GTP-Rac1 was markedly overexpressed in DN mice and its levels were significantly decreased in response to BSHX decoction. Similarly, levels of p-PAK1 and p-p38MAPK which indicate Rac1 activation, were reduced on treatment with BSHX decoction. Together, our data demonstrated that BSHX decoction ameliorated renal function and podocyte epithelial-mesenchymal transition via inhibiting Rac1/PAK1/p38MAPK signaling pathway in high-fat diet/streptozotocin-induced diabetic mice. Further, we generated a quality control standard and numerous potential active compounds from BSHX decoction for DN.

来源:Front Pharmacol,查看原文。版权归原作者所有。

引用

  1. Wang W, Long H, Huang W, et al. Bu-Shen-Huo-Xue Decoction Ameliorates Diabetic Nephropathy by Inhibiting Rac1/PAK1/p38MAPK Signaling Pathway in High-Fat Diet/Streptozotocin-Induced Diabetic Mice. Front Pharmacol. 2020. PMID: 33343355. doi:10.3389/fphar.2020.587663

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。